Explore
Validate
LearnABIN252639
antibody from antibodies-online
Targeting: TERF2
TRBF2, TRF2
Western blot
Immunocytochemistry Immunoprecipitation Immunohistochemistry Chromatin ImmunoprecipitationAntibody data
- Antibody Data
- Antigen structure
- References [8]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN252639 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-TBP-Like 1 (TBPL1) antibody
- Antibody type
- Polyclonal
- Description
- Protein G purified
- Reactivity
- Human, Mouse
- Host
- Goat
- Vial size
- 0.1 mg
- Storage
- Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
- Handling
- Avoid freeze-thaw cycles
Submitted references Association of a Platinum Complex to a G-Quadruplex Ligand Enhances Telomere Disruption.
Involvement of telomerase reverse transcriptase in heterochromatin maintenance.
Application of two-dimensional gel-based mass spectrometry to functionally dissect resistance to targeted cancer therapy.
Platination of telomeric DNA by cisplatin disrupts recognition by TRF2 and TRF1.
MLL associates with telomeres and regulates telomeric repeat-containing RNA transcription.
The nuclear lamina promotes telomere aggregation and centromere peripheral localization during senescence of human mesenchymal stem cells.
p53 differentially inhibits cell growth depending on the mechanism of telomere maintenance.
Interaction of EBV latent origin of replication with the nuclear matrix: identification of S/MAR sequences and protein components.
Charif R, Granotier-Beckers C, Bertrand HC, Poupon J, Ségal-Bendirdjian E, Teulade-Fichou MP, Boussin FD, Bombard S
Chemical research in toxicology 2017 Aug 21;30(8):1629-1640
Chemical research in toxicology 2017 Aug 21;30(8):1629-1640
Involvement of telomerase reverse transcriptase in heterochromatin maintenance.
Maida Y, Yasukawa M, Okamoto N, Ohka S, Kinoshita K, Totoki Y, Ito TK, Minamino T, Nakamura H, Yamaguchi S, Shibata T, Masutomi K
Molecular and cellular biology 2014 May;34(9):1576-93
Molecular and cellular biology 2014 May;34(9):1576-93
Application of two-dimensional gel-based mass spectrometry to functionally dissect resistance to targeted cancer therapy.
Klein O, Rohwer N, de Molina KF, Mergler S, Wessendorf P, Herrmann M, Klose J, Cramer T
Proteomics. Clinical applications 2013 Dec;7(11-12):813-24
Proteomics. Clinical applications 2013 Dec;7(11-12):813-24
Platination of telomeric DNA by cisplatin disrupts recognition by TRF2 and TRF1.
Ourliac-Garnier I, Poulet A, Charif R, Amiard S, Magdinier F, Rezaï K, Gilson E, Giraud-Panis MJ, Bombard S
Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry 2010 Jun;15(5):641-54
Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry 2010 Jun;15(5):641-54
MLL associates with telomeres and regulates telomeric repeat-containing RNA transcription.
Caslini C, Connelly JA, Serna A, Broccoli D, Hess JL
Molecular and cellular biology 2009 Aug;29(16):4519-26
Molecular and cellular biology 2009 Aug;29(16):4519-26
The nuclear lamina promotes telomere aggregation and centromere peripheral localization during senescence of human mesenchymal stem cells.
Raz V, Vermolen BJ, Garini Y, Onderwater JJ, Mommaas-Kienhuis MA, Koster AJ, Young IT, Tanke H, Dirks RW
Journal of cell science 2008 Dec 15;121(Pt 24):4018-28
Journal of cell science 2008 Dec 15;121(Pt 24):4018-28
p53 differentially inhibits cell growth depending on the mechanism of telomere maintenance.
Razak ZR, Varkonyi RJ, Kulp-McEliece M, Caslini C, Testa JR, Murphy ME, Broccoli D
Molecular and cellular biology 2004 Jul;24(13):5967-77
Molecular and cellular biology 2004 Jul;24(13):5967-77
Interaction of EBV latent origin of replication with the nuclear matrix: identification of S/MAR sequences and protein components.
Mearini G, Chichiarelli S, Zampieri M, Masciarelli S, D'Erme M, Ferraro A, Mattia E
FEBS letters 2003 Jul 17;547(1-3):119-24
FEBS letters 2003 Jul 17;547(1-3):119-24
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC
